ReviewCurrent treatment options in oncology2023

Immunotherapy in Early-Stage Triple-Negative Breast Cancer: Where Are We Now and Where Are We Headed?

Julia Dixon-Douglas et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.